US6046177A
(en)
*
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
AU775037B2
(en)
*
|
1998-12-09 |
2004-07-15 |
Eli Lilly And Company |
Pellet implant system
|
JP2001517625A
(ja)
*
|
1997-09-25 |
2001-10-09 |
バイエル・アクチエンゲゼルシヤフト |
活性成分放出制御薬物製剤
|
DE69802832T2
(de)
*
|
1997-10-03 |
2002-06-20 |
Warner Lambert Co |
Gepresste nitroglycerintablette und verfahren zu ihrer herstellung
|
US6099865A
(en)
*
|
1998-07-08 |
2000-08-08 |
Fmc Corporation |
Croscarmellose taste masking
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
UA67802C2
(uk)
*
|
1998-10-23 |
2004-07-15 |
Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. |
Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6245352B1
(en)
*
|
1999-04-27 |
2001-06-12 |
Eli Lilly And Company |
Pharmaceutical formulation
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
JP2003508420A
(ja)
*
|
1999-09-02 |
2003-03-04 |
ノストラム・ファーマスーティカルズ・インコーポレイテッド |
経口投与に適した、制御された放出の経口用量
|
DE19941769A1
(de)
*
|
1999-09-02 |
2001-03-08 |
Beiersdorf Ag |
Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
|
US6346231B1
(en)
*
|
1999-10-06 |
2002-02-12 |
Joar Opheim |
Flavored gelatin capsule and method of manufacture
|
US6294013B1
(en)
*
|
1999-12-08 |
2001-09-25 |
Sun Chemical Corporation |
Polysaccharide pigment dispersions
|
US20030148996A1
(en)
*
|
2000-03-31 |
2003-08-07 |
Joseph Rubinfeld |
Camptothecin complexes
|
DK1276470T3
(da)
*
|
2000-04-20 |
2007-06-18 |
Novartis Ag |
Smagskaskerende overtrækssammensætning
|
WO2001082971A2
(en)
*
|
2000-05-02 |
2001-11-08 |
Theravance, Inc. |
Cyclodextrin containing glycopeptide antibiotic compositions
|
US6953586B1
(en)
|
2000-06-08 |
2005-10-11 |
Ivy Animal Health, Inc. |
Growth promoting pharmaceutical implant
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
AR031135A1
(es)
|
2000-10-10 |
2003-09-10 |
Upjohn Co |
Composiciones de antibiotico topico para el tratamiento de infecciones oculares
|
US6566556B2
(en)
*
|
2000-12-19 |
2003-05-20 |
Nippon Shokubai Co., Ltd. |
Method for production of alkanolamine and apparatus therefor
|
WO2002055562A2
(en)
*
|
2001-01-11 |
2002-07-18 |
Eastman Chem Co |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
IN190699B
(de)
*
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
US7034013B2
(en)
*
|
2001-03-20 |
2006-04-25 |
Cydex, Inc. |
Formulations containing propofol and a sulfoalkyl ether cyclodextrin
|
DE10114364A1
(de)
*
|
2001-03-22 |
2002-10-02 |
Heraeus Kulzer Gmbh & Co Kg |
Verfahren zur Herstellung von antibiotischen Kompositen
|
DE10114245A1
(de)
*
|
2001-03-22 |
2002-10-02 |
Heraeus Kulzer Gmbh & Co Kg |
Herstellung und Verwendung einer Antibiotikum-/Antibiotika-Zubereitung
|
EP1269994A3
(de)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
|
WO2003028718A1
(en)
*
|
2001-10-01 |
2003-04-10 |
Smithkline Beecham Corporation |
Novel formulations of carvedilol
|
US7141540B2
(en)
*
|
2001-11-30 |
2006-11-28 |
Genta Salus Llc |
Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
|
WO2003047595A1
(en)
*
|
2001-12-03 |
2003-06-12 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin d compounds
|
US6881726B2
(en)
*
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
DE60322665D1
(de)
|
2002-02-01 |
2008-09-18 |
Pfizer Prod Inc |
Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester-transferproteininhibitors
|
MXPA04008173A
(es)
*
|
2002-02-22 |
2004-11-26 |
Pharmacia Corp |
Formulaciones de farmaco antibiotico oftalmico que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio.
|
WO2003072081A1
(en)
*
|
2002-02-22 |
2003-09-04 |
Pharmacia Corporation |
Ophthalmic formulation with gum system
|
US6869939B2
(en)
*
|
2002-05-04 |
2005-03-22 |
Cydex, Inc. |
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
|
US20040034099A1
(en)
*
|
2002-06-27 |
2004-02-19 |
Ramsey Beverly J. |
Pharmaceutical composition
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
IL152575A
(en)
*
|
2002-10-31 |
2008-12-29 |
Transpharma Medical Ltd |
A skin-to-skin transmission system of water-insoluble drugs
|
IL152573A
(en)
*
|
2002-10-31 |
2009-11-18 |
Transpharma Medical Ltd |
A system for the transmission through the skin of a medical preparation against vomiting and nausea
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
WO2004087121A2
(en)
*
|
2003-03-28 |
2004-10-14 |
Azaya Therapeutics, Inc. |
Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
US20070020196A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
WO2005088655A1
(en)
*
|
2004-03-12 |
2005-09-22 |
The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
A magnetoresistive medium
|
US8198270B2
(en)
*
|
2004-04-15 |
2012-06-12 |
Onyx Therapeutics, Inc. |
Compounds for proteasome enzyme inhibition
|
CN103554222A
(zh)
|
2004-04-15 |
2014-02-05 |
欧尼斯治疗公司 |
用于抑制蛋白酶体酶的化合物
|
AU2015255259B2
(en)
*
|
2004-04-23 |
2017-07-27 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
AU2013201437B2
(en)
*
|
2004-04-23 |
2015-09-03 |
Cydex Pharmaceuticals, Inc |
DPI formulation containing sulfoalkyl ether cyclodextrin
|
CA2562585A1
(en)
*
|
2004-04-23 |
2005-11-10 |
Cydex, Inc. |
Dpi formulation containing sulfoalkyl ether cyclodextrin
|
PT2030981E
(pt)
*
|
2004-05-10 |
2014-10-14 |
Onyx Therapeutics Inc |
Compostos para inibição da enzima proteassoma
|
US20050265955A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
BRPI0513455A
(pt)
*
|
2004-07-22 |
2008-05-06 |
Pfizer Prod Inc |
formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada
|
US9120774B2
(en)
|
2004-11-03 |
2015-09-01 |
University Of Kansas |
Novobiocin analogues having modified sugar moieties
|
US20060105992A1
(en)
*
|
2004-11-08 |
2006-05-18 |
Buchanan Charles M |
Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds
|
ATE499109T1
(de)
*
|
2004-12-07 |
2011-03-15 |
Proteolix Inc |
Zusammensetzung zur proteasomhemmung
|
US20060128653A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of decitabine
|
US20060128654A1
(en)
*
|
2004-12-10 |
2006-06-15 |
Chunlin Tang |
Pharmaceutical formulation of cytidine analogs and derivatives
|
US20060183725A1
(en)
*
|
2005-02-15 |
2006-08-17 |
Thomas Graeser |
Pharmaceutical preparation for oral contraception
|
US7629331B2
(en)
*
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
SI2335707T1
(sl)
|
2005-10-26 |
2015-09-30 |
Cydex Pharmaceuticals, Inc. |
Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo
|
AU2011204957B2
(en)
*
|
2005-10-26 |
2013-12-05 |
Cydex Pharmaceuticals, Inc |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
KR101274417B1
(ko)
|
2005-11-09 |
2013-06-17 |
프로테올릭스, 인코퍼레이티드 |
효소 저해를 위한 화합물
|
US20070135586A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Shreyas Chakravarti |
Polyamide blend compositions formed article and process thereof
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
EP1973550A2
(de)
*
|
2005-12-20 |
2008-10-01 |
Tika Läkemedel AB |
Verfahren und systeme zur abgabe von corticosteroiden mit verbessertem pharmakokinetischem profil
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
JP2009526619A
(ja)
*
|
2006-02-15 |
2009-07-23 |
ティカ レーケメデル アーベー |
質量減量を伴うコルチコステロイドの滅菌
|
US20080069889A1
(en)
*
|
2006-03-07 |
2008-03-20 |
Cherukuri S R |
Compressible resilient granules and formulations prepared therefrom
|
CA2657213C
(en)
|
2006-06-19 |
2017-01-03 |
Proteolix, Inc. |
Peptide epoxyketones for proteasome inhibition
|
US8639782B2
(en)
|
2006-08-23 |
2014-01-28 |
Ebay, Inc. |
Method and system for sharing metadata between interfaces
|
SI2061458T1
(sl)
*
|
2006-09-15 |
2015-04-30 |
Regents Of The University Of Minnesota |
Sestavki topiramata in metode za njihovo uporabo
|
US20090239942A1
(en)
*
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
EP2061587A1
(de)
*
|
2007-04-26 |
2009-05-27 |
Sigmoid Pharma Limited |
Herstellung mehrerer minikapseln
|
KR20150041173A
(ko)
|
2007-04-27 |
2015-04-15 |
사이덱스 파마슈티칼스, 인크. |
클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
|
US7960353B2
(en)
*
|
2007-05-10 |
2011-06-14 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
US20110177161A1
(en)
*
|
2007-05-24 |
2011-07-21 |
Dr. Reddy's Laboratories Limited |
Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin
|
ES2639130T3
(es)
*
|
2007-06-06 |
2017-10-25 |
Basf Se |
Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración
|
US20100184785A1
(en)
*
|
2007-06-06 |
2010-07-22 |
Basf Se |
Pharmaceutical formulation for the production of chewable tablets and lozenges
|
ES2493641T3
(es)
*
|
2007-06-28 |
2014-09-12 |
Cydex Pharmaceuticals, Inc. |
Administración nasal de soluciones acuosas de corticosteroides
|
MY173938A
(en)
*
|
2007-10-04 |
2020-02-27 |
Onyx Therapeutics Inc |
Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
|
WO2009114365A2
(en)
*
|
2008-03-13 |
2009-09-17 |
Mallinckrodt Inc. |
Multi-function, foot-activated controller for imaging system
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
WO2010014617A1
(en)
*
|
2008-07-28 |
2010-02-04 |
University Of Kansas |
Heat shock protein 90 inhibitor dosing methods
|
PE20120059A1
(es)
|
2008-10-21 |
2012-02-27 |
Onyx Therapeutics Inc |
Combinaciones farmaceuticas con epoxicetonas peptidicas
|
WO2010053487A1
(en)
|
2008-11-07 |
2010-05-14 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
CN104958296B
(zh)
|
2008-11-15 |
2017-12-01 |
麦林塔医疗有限公司 |
抗微生物组合物
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
TWI504598B
(zh)
|
2009-03-20 |
2015-10-21 |
Onyx Therapeutics Inc |
結晶性三肽環氧酮蛋白酶抑制劑
|
EP2238973A1
(de)
|
2009-04-07 |
2010-10-13 |
Cephalon France |
Lyophilisierte Präparate von Proteasominhibitoren
|
KR20190071006A
(ko)
|
2009-05-13 |
2019-06-21 |
사이덱스 파마슈티칼스, 인크. |
프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
|
EP2434886B1
(de)
|
2009-05-29 |
2019-10-16 |
CyDex Pharmaceuticals, Inc. |
Injizierbare melphalan-zusammensetzungen umfassend ein cyclodextrin-derivat und verfahren zur herstellung und verwendung davon
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
US8492538B1
(en)
|
2009-06-04 |
2013-07-23 |
Jose R. Matos |
Cyclodextrin derivative salts
|
SI2442791T1
(sl)
|
2009-06-16 |
2020-03-31 |
Pfizer Inc. |
Dozirna oblika apiksabana
|
WO2011041593A1
(en)
*
|
2009-09-30 |
2011-04-07 |
University Of Kansas |
Novobiocin analogues and treatment of polycystic kidney disease
|
WO2011060179A1
(en)
|
2009-11-13 |
2011-05-19 |
Onyx Therapeutics, Inc |
Use of peptide epoxyketones for metastasis suppression
|
WO2011103150A2
(en)
|
2010-02-18 |
2011-08-25 |
Cephalon, Inc. |
Lyophilized preparations of bendamustine
|
EP2538923A2
(de)
|
2010-02-22 |
2013-01-02 |
Lupin Limited |
Geschmacksmaskiertes pulver zur suspensionszusammensetzungen aus methylprednisolon
|
MA34133B1
(fr)
|
2010-03-01 |
2013-04-03 |
Onyx Therapeutics Inc |
Composes pour inhibiteurs de l'immunoproteasome
|
AU2011245630B2
(en)
|
2010-04-07 |
2014-07-03 |
Onyx Therapeutics, Inc. |
Crystalline peptide epoxyketone immunoproteasome inhibitor
|
EP2621475A1
(de)
|
2010-10-02 |
2013-08-07 |
Link Research&Grants Corporation |
Behandlung von tinnitus und zugehörigen dysfunktionen des gehörs
|
ES2773753T3
(es)
|
2010-11-01 |
2020-07-14 |
Mei Pharma Inc |
Compuestos isoflavonoides y métodos para el tratamiento del cáncer
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
TWI544922B
(zh)
*
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠(olopatadine)眼用組成物
|
ES2911427T3
(es)
|
2011-09-18 |
2022-05-19 |
Euro Celtique Sa |
Composición farmacéutica que comprende un inhibidor HDAC y un ciclopolisacárido
|
PL2806877T3
(pl)
|
2012-01-23 |
2020-06-01 |
Sage Therapeutics, Inc. |
Formulacje neuroaktywnego steroidu zawierające kompleks allopregnanolonu i eteru sulfobutylowego beta-cyklodekstryny
|
AR092790A1
(es)
|
2012-02-01 |
2015-05-06 |
Euro Celtique Sa |
Derivados bencimidazolicos del acido hidroxamico
|
DK2814849T3
(da)
|
2012-02-15 |
2020-03-09 |
Cydex Pharmaceuticals Inc |
Fremgangsmåde til fremstilling af cyclodextrin-derivater
|
US9493582B2
(en)
|
2012-02-28 |
2016-11-15 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
WO2014011695A2
(en)
|
2012-07-09 |
2014-01-16 |
Onyx Therapeutics, Inc. |
Prodrugs of peptide epoxy ketone protease inhibitors
|
MX2015002252A
(es)
|
2012-08-21 |
2015-07-21 |
Sage Therapeutics Inc |
Metodos para tratar epilepsia o estado de epilepsia.
|
JP6557144B2
(ja)
|
2012-10-22 |
2019-08-07 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法
|
GB201312737D0
(en)
*
|
2013-07-17 |
2013-08-28 |
Univ Greenwich |
Cyclodextrin
|
GB201409488D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
GB201409485D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
WO2015195448A1
(en)
|
2014-06-18 |
2015-12-23 |
Eli Lilly And Company |
Transdermal formulations of pergolide and uses thereof
|
EP3183295B1
(de)
|
2014-08-22 |
2023-08-02 |
CyDex Pharmaceuticals, Inc. |
Fraktionierte alkylierte cyclodextrinzusammensetzungen und verfahren zur herstellung und verwendung davon
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
CN116139125A
(zh)
|
2015-02-02 |
2023-05-23 |
梅制药公司 |
联合治疗
|
EP3270941B1
(de)
|
2015-03-19 |
2021-05-26 |
Cydex Pharmaceuticals, Inc. |
Zusammensetzungen mit silymarin und sulfoalkylethercyclodextrin und verfahren zur verwendung davon
|
US11266631B2
(en)
|
2016-10-11 |
2022-03-08 |
Purdue Pharmaceutical Products L.P. |
Hodgkin lymphoma therapy
|
JP2019535722A
(ja)
|
2016-11-18 |
2019-12-12 |
アイキュリス アンチ−インフェクティブ キュアズ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
修飾シクロデキストリン及び酸性化剤に基づくアミジン置換ベータ−ラクタム化合物の新規製剤、それらの製造及び抗菌医薬組成物としての使用
|
EP3544614A4
(de)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
Orale testosteron-undecanoat-therapie
|
AU2018263924A1
(en)
|
2017-05-03 |
2019-11-21 |
Cydex Pharmaceuticals, Inc. |
Composition containing cyclodextrin and busulfan
|
GB201709405D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating ovarian cancer
|
GB201709402D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating t-pll
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
GB201709406D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro-Cletique S A |
Compounds for treating TNBC
|
US20200276209A1
(en)
|
2017-09-11 |
2020-09-03 |
Sage Therapeutics, Inc. |
Methods of treating epilepsy or status epilepticus
|
CN114555127A
(zh)
|
2019-08-06 |
2022-05-27 |
L.E.A.F.控股集团公司 |
制备聚谷氨酸化抗叶酸剂的方法以及它们的组合物的用途
|
EP4168426A1
(de)
|
2020-06-18 |
2023-04-26 |
The University of Bristol |
Fettsäurekomplexe des coronavirus-spike-proteins und deren verwendung
|
EP4243805A1
(de)
|
2020-08-07 |
2023-09-20 |
Gbiotech S.À.R.L. |
Kombinationstherapien zur behandlung von coronavirusinfektion
|
CN114128914B
(zh)
*
|
2021-12-02 |
2023-02-10 |
云南中烟工业有限责任公司 |
一种包合物、其制备方法及用途
|